CTSH vs MGNX · P/E 12, rev $21.11B vs rev $39.6M
Cognizant Technology Solutions Corp Class A (CTSH) versus MacroGenics Inc (MGNX) — a side-by-side from cached financials, not a winner call.
Cognizant Technology Solutions Corp Class A (CTSH) is a information technology services company listed on US.
MacroGenics Inc (MGNX) is a biotechnology company listed on NASDAQ.
Latest reported CTSH revenue for 2025-12-31 was $21.11B. Net income was $2.23B. Revenue was up 7.0% from 2024-12-31 to 2025-12-31. CTSH currently screens at market cap $25.17B and trailing P/E 11.5.
Latest reported MGNX revenue for 2026-06-30 was $39.6M. Net income was -$17.3M. Revenue was up 90.4% from 2026-03-31 to 2026-06-30. MGNX currently screens at market cap $246.6M.
CTSH currently screens at market cap $25.17B and trailing P/E 11.5. MGNX currently screens at market cap $246.6M.
Not investment advice. Open the CTSH and MGNX stock pages for the full models.
Not investment advice.